Jane Street
USNA icon

Jane Street’s Usana Health Sciences USNA Stock Holding History

Jane Street’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,800
Closed -$573K – 7954
2020
Q2 		$573K Buy
+7,800
New +$612K ﹤0.01% 4871
2013
Q3 		– Sell
-25,800
Closed -$934K – 3143
2013
Q2 		$934K Buy
+25,800
New +$784K 0.02% 967

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's USNA Position: Q2 2026 in Review

Jane Street sold out of Usana Health Sciences (USNA) in Q2 2026, closing a stake of 27,696 shares — an estimated $484K sold.

Jane Street first reported a position in USNA in Q2 2013 and held it in 20 quarters. The position peaked at $1.89M in Q4 2025. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Jane Street reported no remaining Usana Health Sciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 27,696 Usana Health Sciences shares in Q2 2026, an estimated $484K.
  • Jane Street first reported a position in Usana Health Sciences in Q2 2013 and held it in 20 quarters.
  • Jane Street's Usana Health Sciences position peaked at $1.89M in Q4 2025.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.